300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical VC Funds & Investors in Oceania (October 2023)

The most active venture capital funds investing in Oceania Medical startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Oceania Medical startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Brandon Capital Partners
VC Fund
11 Australia, United States, United Kingdom Series A, Seed, Series B Biotechnology, Health Care, Medical $642k–$25M
Medical Research Commercialisation Fund (MRCF)
VC Fund
7 Australia, United States, United Kingdom Series A, Seed, Series B Biotechnology, Health Care, Medical $1.3M–$13M
Artesian VC
VC Fund
7 Australia, United States, Hong Kong Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $70k–$12M
Uniseed Ventures
VC Fund
5 Australia, United States, United Kingdom Series A, Seed Biotechnology, Manufacturing, Health Care $364k–$6.4M
Stoic VC
VC Fund
4 Australia, United States, United Kingdom Seed, Series A Biotechnology, Medical, Health Care
Main Sequence Ventures
VC Fund
4 Australia, United States, Philippines Series A, Seed, Series B Software, Artificial Intelligence, Information Technology $1.3M–$49M
Transition Level Investments
VC Fund
3 Australia, United States Seed, Pre-Seed, Series A SaaS, Artificial Intelligence, Software $60k–$2.4M
Right Click Capital
VC Fund
3 Australia, Singapore, United States Seed, Series A Software, Artificial Intelligence, SaaS $64k–$15M
Giant Leap Fund
VC Fund
3 Australia, United States, United Kingdom Seed, Series A Health Care, Information Technology, SaaS $771k–$22M
IP Group
VC Fund
2 United Kingdom, United States, Australia Seed, Series A, Series B Health Care, Biotechnology, Therapeutics $369k–$61M
Matū Fund
VC Fund
2 New Zealand, United States Seed Biotechnology, Robotics, Nanotechnology
Regal Funds Management
VC Fund
2 Australia, United States, United Kingdom Series B, Convertible Note Software, Financial Services, FinTech $1.6M–$25M
Jolimont Global Mining Systems
VC Fund
2 Australia, United States Seed, Convertible Note Construction, Software, SaaS
Enterprise Angels
VC Fund
2 New Zealand, United States, United Kingdom Seed, Angel Software, Information Technology, Health Care $149k–$2.4M
Pacific Channel
VC Fund
2 New Zealand Seed, Series A Medical Device, Medical, Health Care
Folklore Ventures
VC Fund
2 Australia, New Zealand, United States Seed, Series A Software, Apps, Information Technology $250k–$15M
Clinton Capital Partners
VC Fund
2 Australia, United States Seed, Series A, Series B Software, E-Commerce, Health Care $321k–$8.6M
Starfish Ventures
VC Fund
2 United States, Australia, Philippines Series A, Series B Software, Enterprise Software, Information Technology $642k–$14M
EVP
VC Fund
2 Australia, New Zealand, Canada Series A, Seed Software, SaaS, E-Commerce $899k–$5.1M
Blackbird Ventures
VC Fund
2 Australia, United States, New Zealand Seed, Series A, Series B Software, SaaS, Information Technology $29k–$28M
Carthona Capital
VC Fund
2 Australia, United States, Latvia Seed, Series A, Series B Software, Financial Services, Artificial Intelligence $321k–$59M
Horizons Ventures
VC Fund
2 United States, United Kingdom, Canada Series A, Series B, Seed Biotechnology, Artificial Intelligence, Software $750k–$70M
Icehouse Ventures
VC Fund
2 New Zealand, United States, Australia Seed, Series A Software, SaaS, Information Technology $450k–$21M
QIC BioVentures
VC Fund
1 Australia Series A Medical, Health Care, Biotechnology
Lilly Ventures
VC Fund
1 United States, Israel, Australia Series C, Series B, Series A Biotechnology, Health Care, Therapeutics $4M–$44M
Global from Day One
VC Fund
1 New Zealand, United States, China Seed, Series A Software, SaaS, Medical Device $595k–$5M
AustralianSuper
VC Fund
1 Australia, United States, United Kingdom Series A, Series C Information Technology, Hotel, Solar
CSIRO
VC Fund
1 Australia, United States Series A Software, Health Care, Solar $4.5M–$6M
Mass Medical Angels
VC Fund
1 United States, Israel, Australia Series A, Seed, Series B Health Care, Biotechnology, Medical Device $500k–$17M
HESTA
VC Fund
1 Australia Series A, Series B, Series C Sensor, Medical, Aerospace
Auckland UniServices
VC Fund
1 New Zealand Seed, Pre-Seed Medical, Marketing, Health Care
Watermark Funds Management
VC Fund
1 Australia Series A Medical, Software, Health Care
VU Venture Partners
VC Fund
1 United States, Colombia, India Seed, Series A Software, Health Care, Machine Learning $120k–$57M
K1W1
VC Fund
1 New Zealand, United States Seed, Series A Software, Biotechnology, SaaS
Hillfarrance Venture Capital
VC Fund
1 New Zealand Seed, Pre-Seed Software, Machine Learning, SaaS $460k–$1.2M
Washington H. Soul Pattinson
VC Fund
1 Australia Series A Software, Hotel, Men's
SG Hiscock
VC Fund
1 Australia Series A Software, Legal, Medical
Uniservices
VC Fund
1 New Zealand Seed, Pre-Seed Medical Device, SaaS, Audio
OneVentures
VC Fund
1 Australia, United States, Israel Series A, Debt Financing Software, Health Care, Information Technology $1.5M–$20M
Medibank
VC Fund
1 Australia Corporate Round Medical, Health Care, Information and Communications Technology (ICT)
CVC Capital Partners
VC Fund
1 United States, United Kingdom, Spain Private Equity, Post-IPO Equity Software, Retail, Financial Services $80M–$1.5B
Telstra Ventures
VC Fund
1 United States, China, Australia Series B, Series C, Series A Software, Information Technology, SaaS $6.7M–$120M
Side Stage Ventures
VC Fund
1 Australia Seed Medical, Hospital, Wellness
Skip Capital
VC Fund
1 Australia, Canada, United States Series A, Seed, Series B Software, SaaS, Artificial Intelligence $1M–$75M
Cure Kids Ventures
VC Fund
1 New Zealand Seed, Pre-Seed, Series A Medical Device, SaaS, Medical
Sante Ventures
VC Fund
1 United States, Canada, New Zealand Series A, Series B, Series C Health Care, Biotechnology, Medical $1M–$30M
Tyson & Blake
VC Fund
1 Australia Seed Medical, Facial Recognition, Artificial Intelligence
Movac
VC Fund
1 New Zealand, United States, Australia Seed, Series A Software, E-Commerce, SaaS $774k–$16M
New Zealand Growth Capital Partners
VC Fund
1 New Zealand, United States Seed, Series A Software, SaaS, Manufacturing $1.3M–$6.2M
HTC
VC Fund
1 United States, Taiwan, China Series A, Seed Virtual Reality, Software, Augmented Reality $1.2M–$50M
Access all 50 VC funds in Oceania Medical startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Brandon Capital Partners
VC Fund · Melbourne, Victoria, Australia · 11 investments in Oceania Medical startups

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 39
  • Round size: Seed $642k–$6.4M; Series A $4M–$20M; Series B $5M–$25M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $210M in 2019

Portfolio highlights

  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • Entact Bio — Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.
  • NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
Show all investments...

Medical Research Commercialisation Fund (MRCF)
VC Fund · Melbourne, Victoria, Australia · 7 investments in Oceania Medical startups

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 25
  • Round size: Series A $1.3M–$13M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Glyscend — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
  • Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
  • Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Show all investments...

Artesian VC
VC Fund · Melbourne, Victoria, Australia · 7 investments in Oceania Medical startups, 13 in the past 12 months

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Australia, United States, Hong Kong

Investor stats

  • Total investments: 172
  • Round size: Seed $96k–$2.4M; Pre-Seed $70k–$1.5M; Series A $3.3M–$12M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • ZoomAgri — ZOOMAGRI provides an assessment of agricultural commodities to all participants of Agri supply chain via AI, computer vision and IoT.
  • Supplynote — End-to-end supply chain management tool to track inventory, orders, payments and suppliers online
  • Navi Medical Technologies — Navi Medical Technologies is a medical device development company.
Show all investments...

Uniseed Ventures
VC Fund · Brisbane, Queensland, Australia · 5 investments in Oceania Medical startups

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Health Care
  • Stage:Series A, Seed
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 56
  • Round size: Seed $364k–$2M; Series A $1.3M–$6.4M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: May invest from a new fund soon — raised $13M in 2017

Portfolio highlights

  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Morse Micro — Smarter, farther, better. Meet the latest Wi-Fi, HaLow, 802.11ah. 10X FARTHER>1Km range, 100x area, 1000x volume 10X EFFICIENCYMulti-year on a single
  • Tiny Bright Things — Melbourne-based company Tiny Bright Things was cofounded in 2020 by long-time research collaborators Ray Dagastine and Chris Bolton. We invented Halo microscopy to transform the way researchers and manufacturers look at small or transparent things. This helps manufacturers in areas like agrichemicals and pharmaceuticals (where the size and shape ofpowders are critical) and researchers at every stage of discovery— particularly in nanotechnology (where samples are especially tiny) and life sciences (where samples are often also transparent).
Show all investments...

Stoic VC
VC Fund · Sydney, New South Wales, Australia · 4 investments in Oceania Medical startups

Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Series A
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 20
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture. Our high-level introduction and detailed insights into our innovative solutions, exceptional collaborations, and dedicated team make it easy to understand WHO we are, WHAT we do, and HOW we do it. Stay updated with valuable resources, customer portal, and regular content via our blog. Contact us today to collaborate and optimize your farm's productivity and sustainability.
  • Lenexa Medical — Lenexa Medical is driving towards better healthcare solutions for patients in hospital and aged-care by preventing pressure injuries and empowering clinicans.
Show all investments...

Main Sequence Ventures
VC Fund · Sydney, New South Wales, Australia · 4 investments in Oceania Medical startups, 15 in the past 12 months

We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United States, Philippines

Investor stats

  • Total investments: 65
  • Round size: Seed $1.3M–$6M; Series A $3.8M–$22M; Series B $12M–$49M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: May invest from a new fund soon — raised $161M in 2021

Portfolio highlights

  • Endua — Endua is building the next generation of clean energy deep storage to power communities, remote industries and off-grid infrastructure at the flick of a switch - all day and night
  • Jdoodle — JDoodle is an Online Compiler, Editor, IDE for Java, C, C++, PHP, Perl, Python, Ruby and many more. You can run your programs on the fly online, and you can save and share them with others. Quick and Easy way to compile and run programs online.
  • Number 8 bio — Number 8 bio objective is to decarbonize agriculture while feeding the world's rising population. This can be accomplished by harnessing the power of trillions of carbon-hungry bacteria that feed on harmful greenhouse gases and turn them into profitable animal feeds.
Show all investments...

Transition Level Investments
VC Fund · Brisbane, Queensland, Australia · 3 investments in Oceania Medical startups

Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies. Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.

Show more...

Investment focus

  • Industry: SaaS, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Australia, United States

Investor stats

  • Total investments: 17
  • Round size: Seed $835k–$2.4M; Pre-Seed $60k–$1.5M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Kapiche — Instant insights. No set up or coding. The Kapiche feedback analytics platform helps you ingest and analyze mountains of customer feedback in minutes.
  • FloodMapp — Enhance operational efficiency, lead time, situational awareness and decision making using FloodMapp rapid flood mapping software.
  • Chipper Cash — Join over 5 million people securely sending and receiving money with Chipper Cash. Great app to send and receive money across a number of countries, highly recommended as a money transfer alternative.
Show all investments...

Right Click Capital
VC Fund · Sydney, New South Wales, Australia · 3 investments in Oceania Medical startups

Right Click Capital - Australian Venture Capital Firm

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A
  • Geography: Australia, Singapore, United States

Investor stats

  • Total investments: 55
  • Round size: Seed $64k–$3M; Series A $3.1M–$15M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Cydarm — A case management platform that enables cybersecurity operations teams to collaborate, integrate, and respond with ease.
  • Reejig — At Reejig, we believe in zero wasted potential in people and in business – and that starts with harnessing the skills you have within your organisation. Our workforce intelligence platform provides 100% visibility of your people’s skills, potential, passions and experiences, creating a powerful central nervous system for all talent decisions.Powered by the world’s first independently audited Ethical Talent AI engine, Reejig generates the intelligence to instantly fill roles, track retention risks, mobilise talent to opportunities, pivot talent for reskilling and much more. Plus, we give you the power to ‘nudge’ people to new career opportunities, taking your engagement with internal and external talent to the next level. Put simply, we make workforce agility a reality.Reejig is trusted and used by some of the largest and most complex organisations including Woolworths, KPMG, NSW Government, John Holland, MYOB and UTS, and together we are creating a world where everyone can reach their full potential at work. It’s what we call zero-wasted potential in people and in business.
  • Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation
Show all investments...

Giant Leap Fund
VC Fund · Melbourne, Victoria, Australia · 3 investments in Oceania Medical startups

Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.

Show more...

Investment focus

  • Industry: Health Care, Information Technology, SaaS
  • Stage:Seed, Series A
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 36
  • Round size: Seed $771k–$12M; Series A $2.7M–$22M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: May invest from a new fund soon — raised $9.6M in 2018

Portfolio highlights

  • Fortanix — Fortanix is building a new security category with its Runtime Encryption(R) technology using Intel SGX. Just like encryption today protects data at rest and data during motion, Runtime Encryption(R) keeps keys, data, and applications completely protected even when infrastructure has been compromised and even root users are malicious.Fortanix's Self-Defending Key Management Service (SDKMS) is a next-generation cloud native solution for your enterprise encryption needs. It offers key generation, management, distribution, encryption-as-a-service, HSM, KMIP, and tokenization all rolled-in as a single product the highest possible level of security and cloud scale. Available as both FIPS certified appliance and a globally available SaaS (with Equinix's strong SLA), SDKMS offers incredible simple central management, server-side load balancing, central tamper-proof logging, RESTful APIs, and Runtime Encryption(R) plugin to run custom code.Fortanix's Runtime Encryption(R) Platform allows customers to bring any docker container and run them securely inside Intel SGX without any modification. It allows customers to share data with each other without losing control of the data, run analytics on sensitive data, run applications securely in remote cloud, move PII-heavy sensitive data to public cloud, etc. Fortanix's Enclave Development Platform (EDP) allows customers to write Rust code to run natively as SGX enclaves. Supported by mainline Rust compiler, developers find EDP as the easiest and the most secure way of developing new applications.In the short time, Fortanix has developed strategic partnership with Equinix and IBM cloud and counts multiple F50 companies as its customers. Fortanix is a Gartner Cool Vendor and also was runner up in RSA Innovation Sandbox among 500+ security companies where judges called it "holy grail of security". Fortanix has more than ten patents pending for its innovation.
  • Mindset Health — Mindset Health is a digital therapeutics company that helps people manage chronic health issues like irritable bowel syndrome and anxiety with app-based hypnotherapy.
  • More Good Days — More Good Days offers evidence-based pain management programes, education, and health services.
Show all investments...

IP Group
VC Fund · London, England, United Kingdom · 2 investments in Oceania Medical startups, 9 in the past 12 months

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Australia

Investor stats

  • Total investments: 157
  • Round size: Seed $369k–$6.4M; Series A $1.8M–$17M; Series B $7.4M–$61M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • AccelerComm — Our patented, market-leading IP solutions for 4G and 5G are configurable for quick, high-performance implementations across a wide range of applications.
  • Deep Render — Deep Render Ltd. is a spin-out from the Department of Computing at Imperial College London. We are a London based AI start-up that is developing the next generation of media compression algorithms. Our proprietary and patented technology is at the forefront of machine learning research. Furthermore, our Biological Image Compression results arestate-of-the-art, providing at least a 50% efficiency gain over the previous standards
  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Matū Fund
VC Fund · Auckland, Auckland, New Zealand · 2 investments in Oceania Medical startups

Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.

Show more...

Investment focus

  • Industry: Biotechnology, Robotics, Nanotechnology
  • Stage:Seed
  • Geography: New Zealand, United States

Investor stats

  • Total investments: 7
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Ligar — Novel technology to rapidly and cost effectively capture and recover specific molecules or groups of molecules from liquids, such as bioactives, bitter flavours or contaminants from natural extracts, wine, water, juices, coffee and wastewater. [et_pb_column type="1_3"
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • PowerON — Dielectric Elastomers for Soft Robotics
Show all investments...

Regal Funds Management
VC Fund · Sydney, New South Wales, Australia · 2 investments in Oceania Medical startups

Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.

Show more...

Investment focus

  • Industry: Software, Financial Services, FinTech
  • Stage:Series B, Convertible Note
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 71
  • Round size: Series B $7M–$25M; Convertible Note $1.6M–$16M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $48M in 2022

Portfolio highlights

  • Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
  • SendFX — SendFX provides cross-border payment and remittance services to individuals and SMEs.
  • Send Payments — Send is a fast-growing fintech delivering embedded finance solutions to well-known brands.
Show all investments...

Jolimont Global Mining Systems
VC Fund · Denver, Colorado, United States · 2 investments in Oceania Medical startups

Resource Capital Funds is a mining-focused alternative investments firm that partners with companies to build strong, successful, and sustainable businesses.

Show more...

Investment focus

  • Industry: Construction, Software, SaaS
  • Stage:Seed, Convertible Note
  • Geography: Australia, United States

Investor stats

  • Total investments: 5
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • SciAps — SciAps specializes in portable analytical instruments with the power to measure any element. Our industry-leading X-ray fluorescence (XRF) and laser-based (LIBS) analyzers are at work across every major industry.
  • APE Mobile — APE Mobile develops a paperless site application for contractors in Australia. Its site application comprises features, such as operational forms, safety forms, project management, actions and defects, drawings and documents, and redline markup. David Hayward and Matthew Edwards founded APE Mobile in January 2, 2009. Its headquarters is inLeederville in Australia.
  • QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Show all investments...

Enterprise Angels
VC Fund · Tauranga, Gisborne, New Zealand · 2 investments in Oceania Medical startups

Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Angel
  • Geography: New Zealand, United States, United Kingdom

Investor stats

  • Total investments: 98
  • Round size: Seed $149k–$2.4M; Angel $223k–$655k
  • Lead/follow: 7% lead, 93% follow
  • Last fund: May invest from a new fund soon — raised $12M in 2019

Portfolio highlights

  • Cropsy Technologies — Cropsy's mission is to deliver disruptive, scalable technology to every fruit grower to unlock the full potential of their land with insights that were impossible before. Our proprietary AI-enabled hardware allows growers to monitor every plant, understand the whole crop, and track how it changes over time. These insights help growers optimiseall their decision making. The system is a simple tractor add-on, so growers do all their daily operations while Cropsy looks out for problems. Cropsy is poised to set the new gold standard for growing, with recommendations, forecasts, and providing certainty to every grower, every season.
  • Cetogenix — Cetogenix is a clean technology business dedicated to creating long-term solutions to global climate change.
  • Zenno Astronautics — At Zenno Astronautics, our hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
Show all investments...

Pacific Channel
VC Fund · Auckland, Auckland, New Zealand · 2 investments in Oceania Medical startups

Investing in great people solving hard problems to create a better future.

Show more...

Investment focus

  • Industry: Medical Device, Medical, Health Care
  • Stage:Seed, Series A
  • Geography: New Zealand

Investor stats

  • Total investments: 8
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Orbica — Orbica develops innovative, cross-industry location data solutions, services and products.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Show all investments...

Folklore Ventures
VC Fund · Sydney, New South Wales, Australia · 2 investments in Oceania Medical startups

Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.

Show more...

Investment focus

  • Industry: Software, Apps, Information Technology
  • Stage:Seed, Series A
  • Geography: Australia, New Zealand, United States

Investor stats

  • Total investments: 31
  • Round size: Seed $250k–$4.8M; Series A $500k–$15M
  • Lead/follow: 61% lead, 39% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2017

Portfolio highlights

  • Swoop Aero — Transforming how the world moves by making access to the skies seamless.
  • HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
  • SimConverse — SimConverse is a simulation platform that uses generative AI to play the role of any patient, colleague or casualty.
Show all investments...

Clinton Capital Partners
VC Fund · Sydney, New South Wales, Australia · 2 investments in Oceania Medical startups

Clinton Capital Partners is a VC advisory business that specialises in raising capital and growing shareholder returns, for early stage technology companies and their investors. In addition, we invest our own funds to align company, investor and advisor. We have completed >70 successful transactions, and crystallised 14 liquidity events.Clinton Capital Partners has a long and established track record of growing companies, raising capital, conducting mergers, and creating liquidity events. When raising capital, we feel early-stage companies underestimate the time involved, the distraction to the underlying business, and the importance of identifying the “right culturally aligned” investors for their journey.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Australia, United States

Investor stats

  • Total investments: 56
  • Round size: Seed $321k–$2.3M; Series A $707k–$5M; Series B $2.2M–$8.6M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Assembler — The best way to build and launch valuable apps
  • FLK It Over — FLK it over is an Australian-owned and based e-signature solution that offers secure and efficient electronic signature software.
  • Spectrum Support Group — Disability Tech
Show all investments...

Starfish Ventures
VC Fund · Melbourne, Victoria, Australia · 2 investments in Oceania Medical startups

Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.

Show more...

Investment focus

  • Industry: Software, Enterprise Software, Information Technology
  • Stage:Series A, Series B
  • Geography: United States, Australia, Philippines

Investor stats

  • Total investments: 51
  • Round size: Series A $642k–$6.6M; Series B $2.5M–$14M
  • Lead/follow: 53% lead, 47% follow
  • Last fund: May invest from a new fund soon — raised $119M in 2008

Portfolio highlights

  • Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
  • DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,136,169 freelance designers compete to create amazing designs for your business. Start Today!
  • Marani — Marani Health is developing a prenatal care platform which includes a wearable, textile-based product to measure key vital statistics of women and their developing fetus, for use during pregnancy, labor & delivery. The products utilize Artificial Intelligence to better assess health & wellness during pregnancy, labor & delivery. Maraniis collaborating with key partners including The Mayo Clinic.
Show all investments...

EVP
VC Fund · Sydney, New South Wales, Australia · 2 investments in Oceania Medical startups

EVP is an early stage venture capital firm based in Sydney Australia with c. $300M FUM across four fund vintages.Our most recent fund was launched in December 2022 and is a $100M fund. The fund targets early Series-A investments initially with cheque sizes in the range of $0.5 – $5.0 million. Our funds invest in software, are sector agnosticand have a focus on Australian based B2B SaaS companies.Over the years, we’ve backed brilliant founders building global software companies like SiteMinder, Deputy, Ignition and Shippit. We make high conviction investments, underpinned by ambition, pragmatism and a deep understanding of the software journey.

Show more...

Investment focus

  • Industry: Software, SaaS, E-Commerce
  • Stage:Series A, Seed
  • Geography: Australia, New Zealand, Canada

Investor stats

  • Total investments: 51
  • Round size: Seed $899k–$2.2M; Series A $1.3M–$5.1M
  • Lead/follow: 75% lead, 25% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Nexl — Nexl believes that CRM systems should be easy-to-use, affordable, and fully automated. They made it their mission to enable law firm's around the world to take back control over their business development efforts and enable them to grow at their full potential.
  • ClearCalcs — Online structural design software. Calculation tools for shear force, bending moment, cantilever deflection, steel beam calculations, wood, concrete and more.
  • Clipboard — Clipboard is a provider of software for managing extracurricular school activities. Clipboard is an Extracurricular Management System (EMS). An EMS is a purpose-built platform designed to help schools manage the administration of their extracurricular activities.
Show all investments...

Blackbird Ventures
VC Fund · Sydney, New South Wales, Australia · 2 investments in Oceania Medical startups, 27 in the past 12 months

Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: Australia, United States, New Zealand

Investor stats

  • Total investments: 221
  • Round size: Seed $29k–$1.7M; Series A $3.2M–$15M; Series B $7M–$28M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Marqo — A tensor-based search and analytics engine that seamlessly integrates with your applications, websites, and workflows.
  • BioticsAI — Advancing Fetal Ultrasound Screenings Using AI
  • Kiki — Kiki is a subletting startup that matches listers with people looking to rent for up to six months.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Carthona Capital
VC Fund · Sydney, New South Wales, Australia · 2 investments in Oceania Medical startups

Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.

Show more...

Investment focus

  • Industry: Software, Financial Services, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: Australia, United States, Latvia

Investor stats

  • Total investments: 89
  • Round size: Seed $321k–$3M; Series A $2.2M–$16M; Series B $7M–$59M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Josef — Automate lawyer-client conversations, document drafting and providing legal services. Josef is a software platform with a chatbot interface.
  • Pathzero — Pathzero's carbon management platform enables any business to start disclosing corporate carbon emissions and the actions being taken to address them.
  • SafeStack — SafeStack Academy is the New Zealand online cyber security, privacy and secure development training company.
Show all investments...

Horizons Ventures
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 2 investments in Oceania Medical startups, 17 in the past 12 months

Investing in the deep science and technology that can propel humanity towards a radically better future.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Software
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 216
  • Round size: Seed $750k–$11M; Series A $6M–$30M; Series B $8M–$70M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • BioLoomics — BioLoomics is a preclinical stage biotechnology company that uses evolution in a microscope to develop drug discovery tools and protein drugs. Our VariVolve platform tests millions of protein designs for a targeted activity in hours, enabling efficient mining of the vast chemical space of protein designs. A strong advantage of our approach is theuse of whole intact cells as test vessels that capture complex drug behavior not attainable in conventional assays.
  • Erthos — erthos is a producer of biodegradable packaging materials intended to replace traditional polystyrene and polypropylene inputs.
  • ZeroAvia — ZeroAvia is producing the world's first practical zero emission aviation powertrain, initially targeting 20-seat airplanes to start replacing dirty jet fuel in regional transport
Show all investments...

Icehouse Ventures
VC Fund · Auckland, Auckland, New Zealand · 2 investments in Oceania Medical startups, 14 in the past 12 months

Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Seed, Series A
  • Geography: New Zealand, United States, Australia

Investor stats

  • Total investments: 125
  • Round size: Seed $450k–$2.6M; Series A $1.4M–$21M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • DataMasque — Simply mask your sensitive data while maintaining its function for testing, development, training and analytics. DataMasque makes it safe to explore, implement and harness the opportunities that data provides, free from privacy concerns or compromise.
  • Aquila — We're powering the future by building and operating an infinitely scalable energy network.
  • Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
Show all investments...

QIC BioVentures
VC Fund · Brisbane, Queensland, Australia · 1 investments in Oceania Medical startups

QIC BioVentures, previously known as Queensland BioCapital Funds, was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. Like any other QIC Fund, QBF's purpose is to maximize investment returns for QIC's clients. QBF does not provide grants or other formsof assistance.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A
  • Geography: Australia

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Protagonist Therapeutics — Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.
Show all investments...

Lilly Ventures
VC Fund · Indianapolis, Indiana, United States · 1 investments in Oceania Medical startups

Lilly Ventures is the venture capital arm of Eli Lilly and Company responsible for life science investing in North America and Europe. Its primary goal is to facilitate the success of companies in its areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently has $200 million under managementand focuses on three major areas of interest. It partner actively with the management teams of its portfolio companies to realize the potential of their technologies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series C, Series B, Series A
  • Geography: United States, Israel, Australia

Investor stats

  • Total investments: 70
  • Round size: Series A $8.9M–$28M; Series B $15M–$35M; Series C $4M–$44M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — last raise in 2009

Portfolio highlights

  • IpiNovyx Bio — Orange Grove Bio partners with leading research universities to advance preclinical biotech programs in the oncology space. The company leverages its venture capital and drug development expertise to help patients and build biotech ecosystems.
  • Evox Therapeutics — Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes, to develop an entirely new class of therapeutics. Backed by leading Life Sciences Venture Capital groups and supported by a comprehensive intellectualproperty portfolio, Evox’s mission is to positively impact human health by creating novel exosome-based therapeutics for the treatment of various severe diseases with limited options for patients and their families.Evox has created substantial proprietary technology to modify exosomes using various molecular engineering, drug loading, and targeting strategies to facilitate targeted drug delivery to organs of interest, including the brain and the central nervous system. Exosome-based drugs have the potential to address some of the limitations of protein, antibody and nucleic acid-based therapies by enabling delivery to cells and tissues that are currently out of reach using other drug delivery technologies. Evox is leading the development within this emerging therapeutic space.
  • Kymera Therapeutics — Advancing targeted protein degradation to deliver next-generation medicines
Show all investments...

Global from Day One
VC Fund · Auckland, Auckland, New Zealand · 1 investments in Oceania Medical startups

GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.

Show more...

Investment focus

  • Industry: Software, SaaS, Medical Device
  • Stage:Seed, Series A
  • Geography: New Zealand, United States, China

Investor stats

  • Total investments: 27
  • Round size: Seed $595k–$5M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
  • Flowingly — Unlock Team Productivity. Streamline Approvals. Increase Compliance. Easy To Use, No-Code Process Mapping & Workflow Automation Platform.
  • Formus Labs — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Show all investments...

AustralianSuper
VC Fund · Melbourne, Victoria, Australia · 1 investments in Oceania Medical startups

AustralianSuper is run only to benefit members, offering low fees and strong long-term investment returns.

Show more...

Investment focus

  • Industry: Information Technology, Hotel, Solar
  • Stage:Series A, Series C
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 8
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Peel Ports — Peel Ports is a unique network of strategically situated ports, terminals, hubs, shipping lines, and state-of-the-art services.
  • SiteMinder — SiteMinder is the world’s leading open hotel commerce platform, ranked among technology pioneers for opening up every hotel’s access to online commerce. It’s this central role that has earned SiteMinder the trust of tens of thousands of hotels, across 150 countries, to sell, market, manage and grow their business. The global company, headquarteredin Sydney with offices in Bangkok, Berlin, Dallas, Galway, London and Manila, generated more than 100 million reservations worth over US$35 billion in revenue for hotels in the last year prior to the start of the pandemic.
  • Generate Capital — Generate Capital is a finance company that builds, owns, and operates sustainable infrastructure to deliver affordable and reliable resource solutions. The company operates and finances assets in energy, mobility, and water resources.
Show all investments...

CSIRO
VC Fund · Campbell, Victoria, Australia · 1 investments in Oceania Medical startups

As Australia's national science agency and innovation catalyst, we solve the greatest challenges through innovative science and technology.

Show more...

Investment focus

  • Industry: Software, Health Care, Solar
  • Stage:Series A
  • Geography: Australia, United States

Investor stats

  • Total investments: 4
  • Round size: Series A $4.5M–$6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Coviu — Video chat, secure messaging, appointment booking, prescription delivery, in-app assessments, in-call tools. Made for practitioners, clinics and hospitals.
  • Amfora — Amfora is a biotechnology company that is harnessing biology to sustainably nourish the world’s population and enhancing wellness. Amfora's mission is to meet the growing global demand for foods that are high in protein by enhancing the nutritional density of food and feed crops, while reducing the cost of food and the environmental toll onthe planet.
  • Kasada — Kasada stops automated threats and bot attacks from the very first request across web, mobile apps, and APIs. Real-time bot mitigation with no rules to manage.
Show all investments...

Mass Medical Angels
VC Fund · Boston, Massachusetts, United States · 1 investments in Oceania Medical startups

Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Their goal is to provide money and mentoring to the lifescience community to achieve superior returns for their group, and more clinical innovation for the community.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Seed, Series B
  • Geography: United States, Israel, Australia

Investor stats

  • Total investments: 15
  • Round size: Seed $500k–$2.9M; Series A $2.8M–$12M; Series B $1.2M–$17M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Coviu — Video chat, secure messaging, appointment booking, prescription delivery, in-app assessments, in-call tools. Made for practitioners, clinics and hospitals.
  • Capillary Biomedical — Make diabetes management easier with insulin pumps and other innovative products and services from Tandem Diabetes Care.
  • Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Show all investments...

HESTA
VC Fund · Melbourne, Victoria, Australia · 1 investments in Oceania Medical startups

HESTA Super Fund is the Australian industry superannuation fund for people working in health and community services. Become a member today.

Show more...

Investment focus

  • Industry: Sensor, Medical, Aerospace
  • Stage:Series A, Series B, Series C
  • Geography: Australia

Investor stats

  • Total investments: 5
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Morse Micro — Smarter, farther, better. Meet the latest Wi-Fi, HaLow, 802.11ah. 10X FARTHER>1Km range, 100x area, 1000x volume 10X EFFICIENCYMulti-year on a single
  • Citadel Group Ltd — Citadel develops and delivers technology and education solutions to state and federal government departments, and the private sector in Australia. The company operates through Technology and Education segments. The Technology segment sells professional and managed services to government agencies and private enterprises. Its services includestrategic advice, program management, acquisition support, and quality assurance services through consulting, contracting, and placement mechanisms; technology and integration services; and software solutions, products, and managed services for digital health, diagnostic laboratories, and clinical applications. The Education segment delivers a range of nationally-accredited business qualifications that enable students to articulate into second year university or to gain practical skills for employment.
  • Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Auckland UniServices
VC Fund · Perth, Western Australia, Australia · 1 investments in Oceania Medical startups

Auckland UniServices are experts in commercialisation, intellectual property and early stage investing,Supporting and investing in world-class research, technology as well.

Show more...

Investment focus

  • Industry: Medical, Marketing, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: New Zealand

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
  • Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Show all investments...

Watermark Funds Management
VC Fund · Sydney, New South Wales, Australia · 1 investments in Oceania Medical startups

Watermark Funds Management. A specialist long/short investor offering attractive returns while hedging share market risks.

Show more...

Investment focus

  • Industry: Medical, Software, Health Care
  • Stage:Series A
  • Geography: Australia

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
Show all investments...

VU Venture Partners
VC Fund · San Francisco, California, United States · 1 investments in Oceania Medical startups

A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech

Show more...

Investment focus

  • Industry: Software, Health Care, Machine Learning
  • Stage:Seed, Series A
  • Geography: United States, Colombia, India

Investor stats

  • Total investments: 85
  • Round size: Seed $120k–$6M; Series A $5.7M–$57M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • Hadean — Hadean are a venture backed tech startup providing the most simple and secure platform for cloud native development. Intuitive and developer friendly, the Hadean Platform provides a friction free route to a cloud-native infrastructure. It lets you write applications once and deploy anywhere, taking care of setup, configuration, scaling, securityand more.Hadean have developed two flagship applications. Aether Engine provides distributed load balancing for agent-based simulations, while Muxer is a network model that utilises distributed edge networks. The result is spatial simulations of unparalleled size and complexity, where thousands of concurrent users can join and interact. Hadean have found traction in gaming, healthcare, virtual events and defence with industry leading companies such as Microsoft, Minecraft and CAE.
  • MarketForce — MarketForce connects Africa’s informal retail outlets and consumers directly to suppliers of consumer goods and financial services by digitizing orders, delivery, and payments with the aim of solving the last mile distribution challenge.
  • Dayta AI — SaaS Shopper Analytics - Cyclops presents you insightful data like shopper demographics, bahavioral metrics and many more. Drive more sales and traffic with AI now!
Show all investments...

K1W1
VC Fund · Auckland, Auckland, New Zealand · 1 investments in Oceania Medical startups, 6 in the past 12 months

K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.

Show more...

Investment focus

  • Industry: Software, Biotechnology, SaaS
  • Stage:Seed, Series A
  • Geography: New Zealand, United States

Investor stats

  • Total investments: 61
  • Lead/follow: no public data

Portfolio highlights

  • Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
  • Aquafortus — Aquafortus specializes in providing enviornmental services and commercializes proprietary zero liquid discharge technology.
  • Mint Innovation — Founded in 2016, members of the Mint Innovation team have a strong background in chemistry, biotechnology, and leveraging IP in the industrial sector. They are scaling their technology in their Auckland plant and labs to demonstrate the commercial application of their biometallurgy processes for metal recovery.
Show all investments...

Hillfarrance Venture Capital
VC Fund · 1 investments in Oceania Medical startups

We exist to serve great entrepreneurs with honest advice and education, investment capital that is fair, and an open door to our international network and connections.

Show more...

Investment focus

  • Industry: Software, Machine Learning, SaaS
  • Stage:Seed, Pre-Seed
  • Geography: New Zealand

Investor stats

  • Total investments: 6
  • Round size: Pre-Seed $460k–$1.2M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Segna — Extract trends across your users. Build products that they love.
  • Mobli — At Mobli we provide everything you need to build a great customer experience and optimise your mobility services with no long term commitments.
  • Floating Rock Studio — Floating Rock Studio
Show all investments...

Washington H. Soul Pattinson
VC Fund · Sydney, New South Wales, Australia · 1 investments in Oceania Medical startups

Washington H. Soul Pattinson (WHSP) is a significant investment house with a portfolio encompassing many industries.

Show more...

Investment focus

  • Industry: Software, Hotel, Men's
  • Stage:Series A
  • Geography: Australia

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
  • InStitchu — InStitchu is an online custom clothier specializing in tailor made menswear. Customers are able to design custom made garments online which are then made to their exact measurements.InStitchu provides tailor made, high quality menswear through a simple online ordering process. Once a customer has added measurements to their profile, a suit orshirt can be ordered in a few minutes and on its way in two weeks. There are multiple ways for a customer to get their measurements perfected and enjoy that “perfect fit” InStitchu customers keep coming back for - our measurement guide will take you on a journey from your living room to the hustle and bustle of our tailor’s studio. Customers can choose from a wide range of globally sourced high quality wool and cotton fabrics, and when you’ve chosen, we’ll deliver your design right to your door. This new approach to shopping is stress free and cuts out the middleman, allowing us to deliver customers luxury tailor made suits and shirts without the high price tag.
  • SiteMinder — SiteMinder is the world’s leading open hotel commerce platform, ranked among technology pioneers for opening up every hotel’s access to online commerce. It’s this central role that has earned SiteMinder the trust of tens of thousands of hotels, across 150 countries, to sell, market, manage and grow their business. The global company, headquarteredin Sydney with offices in Bangkok, Berlin, Dallas, Galway, London and Manila, generated more than 100 million reservations worth over US$35 billion in revenue for hotels in the last year prior to the start of the pandemic.
Show all investments...

SG Hiscock
VC Fund · 1 investments in Oceania Medical startups

SG Hiscock

Show more...

Investment focus

  • Industry: Software, Legal, Medical
  • Stage:Series A
  • Geography: Australia

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
  • Immediation — Sophisticated video conferencing for dispute resolution and legal practice. Built by Lawyers, for Lawyers. Start your free 14-day trial today.
  • Marketplacer — Marketplacer is a global technology Software as a Service (SaaS) platform equipped with all the tools and functionality needed to build a successful and scalable online marketplaces, at speed.
Show all investments...

Uniservices
VC Fund · 1 investments in Oceania Medical startups

Auckland University's commercialisation arm

Show more...

Investment focus

  • Industry: Medical Device, SaaS, Audio
  • Stage:Seed, Pre-Seed
  • Geography: New Zealand

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Formus Labs — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Show all investments...

OneVentures
VC Fund · Sydney, New South Wales, Australia · 1 investments in Oceania Medical startups

OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series A, Debt Financing
  • Geography: Australia, United States, Israel

Investor stats

  • Total investments: 64
  • Round size: Series A $1.5M–$20M; Debt Financing $1.8M–$4M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — raised $128M in 2022

Portfolio highlights

  • Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
  • BiVACOR — BiVACOR is a privately held company founded in 2008. Their staff includes world-class engineers, medical specialists, and business executives, who are diligently working to advance this ground-breaking technology. Together, they have established a strong collaborative network that extends both nationally and internationally. Their worldheadquarters is located in Houston, Texas, USA, and their international office is in Brisbane, Australia.
  • ImmVirX — ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect.
Show all investments...

Medibank
VC Fund · Docklands, Victoria, Australia · 1 investments in Oceania Medical startups

Get Award Winning cover. Voted Outstanding Value Health Insurance for 14 Consecutive Years. Choose from flexible cover options & join online today.

Show more...

Investment focus

  • Industry: Medical, Health Care, Information and Communications Technology (ICT)
  • Stage:Corporate Round
  • Geography: Australia

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Medinet — Streamline your medical practice and improve employee wellness with Medinet's comprehensive practice management and corporate health services.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
CVC Capital Partners
VC Fund · Luxembourg, Luxembourg, Luxembourg · 1 investments in Oceania Medical startups

CVC has six complementary strategies across private equity, secondaries and credit, through which we invest on behalf of pension funds and other leading institutions

Show more...

Investment focus

  • Industry: Software, Retail, Financial Services
  • Stage:Private Equity, Post-IPO Equity
  • Geography: United States, United Kingdom, Spain

Investor stats

  • Total investments: 78
  • Round size: Private Equity $80M–$1.5B
  • Lead/follow: 55% lead, 45% follow
  • Last fund: May invest from a new fund soon — raised $4.5B in 2020

Portfolio highlights

  • ShadowBot — ShadowBot develops a software robot that performs repetitive online tasks. The software robot simulates various operations of humans and performs operations such as mouse clicks, keyboard input, and reading information on any applications, enabling enterprises to improve efficiency and productivity.
  • Works Mate — Works Mate is a job search matching platform for daily workers in the field of construction and architecture sectors.
  • Skybox Security — Skybox provides the industry’s broadest cybersecurity management platform to address security challenges within large, complex networks. By integrating with 130 networking and security technologies, the Skybox Security Suite gives comprehensive attack surface visibility and the context needed for informed action.It was founded in 2002 andheadquartered in San Jose, California.
Show all investments...

Telstra Ventures
VC Fund · San Francisco, California, United States · 1 investments in Oceania Medical startups

Telstra Ventures provide venture capital investment in lighthouse technology companies that are commencing scale. Leveraging data science for scaling new business.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Series B, Series C, Series A
  • Geography: United States, China, Australia

Investor stats

  • Total investments: 113
  • Round size: Series A $6.7M–$15M; Series B $8M–$85M; Series C $16M–$120M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $50M in 2019

Portfolio highlights

  • Safe Security — Safe Security is a leader in AI-driven cyber risk management. Its real-time, data-driven approach empowers organizations to predict and prevent breaches.
  • Super.com — Through rich rewards and everyday savings, Super helps you access more of what you want at better prices, escape overspending, and level up life.
  • Playbook — Playbook is a step-by-step app for growing your money and optimizing taxes so you can live the life you want sooner.
Show all investments...

Side Stage Ventures
VC Fund · Sydney, New South Wales, Australia · 1 investments in Oceania Medical startups

Early stage venture firm investing in Australia´s best pre-seed and seed stage Founders

Show more...

Investment focus

  • Industry: Medical, Hospital, Wellness
  • Stage:Seed
  • Geography: Australia

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • More Good Days — More Good Days offers evidence-based pain management programes, education, and health services.
Show all investments...

Skip Capital
VC Fund · Sydney, New South Wales, Australia · 1 investments in Oceania Medical startups

Skip Capital is a private investment fund investing in technology and infrastructure

Show more...

Investment focus

  • Industry: Software, SaaS, Artificial Intelligence
  • Stage:Series A, Seed, Series B
  • Geography: Australia, Canada, United States

Investor stats

  • Total investments: 45
  • Round size: Seed $1M–$7.1M; Series A $1M–$75M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Neara — Neara electric utility software is a physics-enabled platform that builds 3D interactive models of critical infrastructure networks and assets. Request a demo.
  • Human — Human aims to assist medical professionals and patients to make more statistics selections.
  • Morse Micro — Smarter, farther, better. Meet the latest Wi-Fi, HaLow, 802.11ah. 10X FARTHER>1Km range, 100x area, 1000x volume 10X EFFICIENCYMulti-year on a single
Show all investments...

Cure Kids Ventures
VC Fund · Auckland, Auckland, New Zealand · 1 investments in Oceania Medical startups

Investing in innovation for a healthy childhood Investing in innovation for a healthy childhood About Cure Kids Ventures Cure Kids Ventures is a seed and early stage investment fund that invests in the commercialisation of innovations in products and services with a potential to

Show more...

Investment focus

  • Industry: Medical Device, SaaS, Medical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: New Zealand

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Formus Labs — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
  • Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Show all investments...

Sante Ventures
VC Fund · Austin, Texas, United States · 1 investments in Oceania Medical startups

Santé Ventures is a life sciences venture capital firm that invests exclusively in early-stage companies developing innovative new medical technologies or healthcare delivery models. The firm was founded in 2006 and has $281 million in capital under management in two funds.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Canada, New Zealand

Investor stats

  • Total investments: 81
  • Round size: Series A $1M–$25M; Series B $2.6M–$30M; Series C $3.5M–$12M
  • Lead/follow: 70% lead, 30% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • BeeKeeperAI — BeeKeeperAI is a zero trust collaboration platform protecting both algorithm IP and regulated data.
  • Solu Therapeutics — Solu Therapeutics is a precision-medicine-focused company developing therapeutics to eliminate disease-driving cells.
  • Surgical Safety Technologies — Surgical Safety Technologies delivers data-driven AI technology to hospitals for safe surgeries. It empowers surgeons with an objective assessment of technical and non-technical proficiency using academically validated frameworks.
Show all investments...

Tyson & Blake
VC Fund · London, England, United Kingdom · 1 investments in Oceania Medical startups

Tyson & Blake We identify growth companies with unique approaches and innovative technologies that have the potential to make a profound contribution to society.We develop inspiring businesses that share our goals and our values.We create a positive impact and long-term value for our investors, the companies we invest in and the communitieswe live in.

Show more...

Investment focus

  • Industry: Medical, Facial Recognition, Artificial Intelligence
  • Stage:Seed
  • Geography: Australia

Investor stats

  • Total investments: 2
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Strong Room — Strong Room focused on improving patient outcomes and accelerating administrative effectiveness of providers through facial recognition and AI analytics.
Show all investments...

Movac
VC Fund · Wellington, Wellington, New Zealand · 1 investments in Oceania Medical startups

Movac is New Zealand's most experienced technology investor and is deeply integrated into the Kiwi tech sector. We've been actively investing since 1998.

Show more...

Investment focus

  • Industry: Software, E-Commerce, SaaS
  • Stage:Seed, Series A
  • Geography: New Zealand, United States, Australia

Investor stats

  • Total investments: 30
  • Round size: Seed $1.4M–$4.3M; Series A $774k–$16M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Atomic — Atomic embeds native, actionable customer interaction inside your iOS, Android or web app. Turn your customer data and insights into loyalty, retention and conversion.
  • ZeroJet — ZeroJet is the first jet propulsion system to be designed specifically for an electric motor, delivering the perfect balance of performance and runtime.
  • Mint Innovation — Founded in 2016, members of the Mint Innovation team have a strong background in chemistry, biotechnology, and leveraging IP in the industrial sector. They are scaling their technology in their Auckland plant and labs to demonstrate the commercial application of their biometallurgy processes for metal recovery.
Show all investments...

New Zealand Growth Capital Partners
VC Fund · 1 investments in Oceania Medical startups

The New Zealand Growth Capital Partners (formerly New Zealand Venture Investment Fund) was established to support early-stage technology companies and to stimulate private investment into this space.

Show more...

Investment focus

  • Industry: Software, SaaS, Manufacturing
  • Stage:Seed, Series A
  • Geography: New Zealand, United States

Investor stats

  • Total investments: 15
  • Round size: Seed $1.3M–$6.2M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Aquafortus — Aquafortus specializes in providing enviornmental services and commercializes proprietary zero liquid discharge technology.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Show all investments...

HTC
VC Fund · Taoyüan, T'ai-wan, Taiwan · 1 investments in Oceania Medical startups

HTC Corp is engaged in the design, development, and manufacture of smartphones and tablets in Taiwan.The company offers PDA phones and smartphones for mobile operators and distributors in Europe, the United States, and Asia. These machines are available as HTC devices and as products individually customized for operators and device partners.The company provides its own HTC self-branded products as well as supports operator-branded products and original equipment manufacturer (OEM) partners. It owns Dopod as a subsidiary company and is a member of the Open Handset Alliance.The company’s products are sold under various brand names such as HTC, Dopod, and Qtek and are often rebranded by major telecommunication carriers. Its products also include pocket PC phones (PDA Phone), ultra mobile phones, HTC kovsky (Sony Ericsson XPERIA X1), and HTC dream (T-mobile G1).HTC Corp was founded by Cher Wang and Peter Chou in 1997. It is headquartered in New Taipei City, Taiwan.

Show more...

Investment focus

  • Industry: Virtual Reality, Software, Augmented Reality
  • Stage:Series A, Seed
  • Geography: United States, Taiwan, China

Investor stats

  • Total investments: 40
  • Round size: Seed $1.2M–$9M; Series A $2.2M–$50M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Hexa — Elevate your eCommerce experience with a 3D tech-stack that lets you create, manage, analyze, and distribute your 3D commerce assets.
  • Camsense — Camsense focuses on R&D and manufacturing of vision space positioning technology. It provides customers with highly precise sensors with its self-developed core algorithm and chips. Its products can be applied in consumer robots, industrial test, and surgeries.
  • Inworld AI — AI for Metaverse
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical VC Funds in Oceania investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 VC funds investing in Oceania Medical startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists